SKU(재고 관리 코드):BT-AP01046
C3aR Polyclonal Antibody
C3aR Polyclonal Antibody
C3a (complement C3a receptor 1) is an anaphylatoxin released during activation of the complement system. The protein encoded by C3AR1 is an orphan G protein-coupled receptor for C3a. Binding of C3a by the encoded receptor activates chemotaxis, granule enzyme release, superoxide anion production, and bacterial opsonization.
The Cadherin-7 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Cadherin-7 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity towards Cadherin-7.
Cadherin-7, also known as CDH7, is a calcium-dependent cell adhesion molecule that plays a crucial role in cell-cell adhesion and tissue morphogenesis. It is primarily expressed in neural tissues, including the brain and spinal cord, as well as in certain epithelial tissues. Dysregulation of Cadherin-7 expression has been implicated in various pathological conditions, such as cancer metastasis and neurodevelopmental disorders.
The Cadherin-7 Polyclonal Antibody has been extensively validated for its specificity and performance in various experimental applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other cadherin family members, ensuring accurate and reliable results.
This antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without compromising its quality. The Cadherin-7 Polyclonal Antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reproducibility.
In summary, the Cadherin-7 Polyclonal Antibody is a valuable tool for researchers studying Cadherin-7 protein expression and its functional implications. Its high specificity, sensitivity, and versatility make it an ideal choice for a wide range of applications in both basic and clinical research.